• About us
  • Donate
  • WADR
  • Contact us
  • Live Stream
Saturday, February 4, 2023
Loud Silence News
Advertisement
  • Ghana News
    • General News
    • Business
    • Education
    • Opinion
  • US News
    • Business
    • Health
    • Human Interest Stories
    • Politics
    • Education
  • Africa News
    • Business
    • Education
    • Health
    • Politics
  • ShowBiz
    • Ghana ShowBiz
    • US Showbiz
    • African ShowBiz
    • World Showbiz
  • Editorials
    • People
  • World News
    • Politics
    • Business
    • Education
    • Health
  • Sports
    • Ghana Sports
    • World Sports
  • WADR
No Result
View All Result
  • Ghana News
    • General News
    • Business
    • Education
    • Opinion
  • US News
    • Business
    • Health
    • Human Interest Stories
    • Politics
    • Education
  • Africa News
    • Business
    • Education
    • Health
    • Politics
  • ShowBiz
    • Ghana ShowBiz
    • US Showbiz
    • African ShowBiz
    • World Showbiz
  • Editorials
    • People
  • World News
    • Politics
    • Business
    • Education
    • Health
  • Sports
    • Ghana Sports
    • World Sports
  • WADR
No Result
View All Result
Loud Silence News
No Result
View All Result
Home US News US Health

Trending Clinical Topic: Remdesivir

Loud Silence Staff by Loud Silence Staff
April 25, 2020
in US Health
0
Why Clinicians’ Spiritual Health Matters in the COVID-19 Crisis
1
SHARES
8
VIEWS
Share on FacebookShare on TwitterShare on WhatsApp

[ad_1]


What your doctor is reading on Medscape.com:

APRIL 24, 2020 — As the COVID-19 pandemic continues, efforts to identify a safe and effective therapy have intensified, leading to this week’s top trending clinical topic. New data on the investigational antiviral drug remdesivir were published April 10 in the New England Journal of Medicine . More than two thirds of severely ill patients with COVID-19 who were given remdesivir for “compassionate use” improved after receiving the medication. Of the 53 patients included in the study, 22 were in the United States, 22 were in Europe or Canada, and 9 were in Japan. Patients received a 10-day course of remdesivir, consisting of 200 mg administered intravenously on day 1, followed by 100 mg daily for the remaining 9 days of treatment.

Although some were encouraged by the results, others warned that limitations in the study make interpreting the data challenging. Josh Farkas, MD, an intensivist from Vermont, provided 11 reasons why the study “reveals nothing” and called the paper “hot garbage” on Twitter. Other physicians lamented the erosion of the peer-review process during the COVID-19 pandemic. The lack of a control group and a small patient sample size have been frequently cited as significant concerns.

In a letter to Gilead, the company behind remdesivir, John Mandrola, MD, calls for blinding and a placebo arm to be added to future trials. Although he applauds the efforts made thus far, Mandrola reiterates that these additions would make the findings more reliable, as “they would be free from the potential biases of clinicians—who, out of the desire to have an available treatment, may consciously or unconsciously make or delay decisions to reduce oxygen and avoid mechanical ventilation in patients in the remdesivir arm.”

At this point, an expert panel of the Infectious Diseases Society of America (IDSA) says evidence is insufficient to recommend any potential pharmacologic therapies for routine use in patients with COVID-19. The effort to validate a treatment approach is massive and global. The World Health Organization  has identified a list of “promising candidates” for COVID-19 treatment, including remdesivir, lopinavir-ritonavir, immunotherapies, and convalescent sera. Around 60 trials involving these therapies have been planned, are recruiting, or have already begun. As the results of those trials become available, the drugs studied will receive immense attention, just as remdesivir did this week.


infographic on remdesivir



Medscape Medical News


© 2020 WebMD, LLC. All rights reserved.



[ad_2]

This content first appear on webmd

You might also like

May 5, 2020 — A roundup of the latest news about COVID-19

Carnival to Resume Some U.S.-Based Cruises

Students Upset by USMLE Response to COVID-19 Demand Changes

Tags: 2019 Novel Coronavirus2019-nCoVantiviralclinical researchclinical studiesclinical trialsCoronavirusdrug/treatment safetyexperimental drugfamciclovirHCoV-229EHCoV-OC43Human coronavirus 229EHuman coronavirus HKU1Human coronavirus OC43off-label indicationpandemicvalacyclovirWuhan coronavirus
Previous Post

Grandmother Nails It On Tik Tok – VIDEO | General Trivia

Next Post

Ex-Apple employees start Fix The Mask to make masks with rubber bands

Loud Silence Staff

Loud Silence Staff

Related Posts

April 14, 2020 — A roundup of the latest news about COVID-19
US Health

May 5, 2020 — A roundup of the latest news about COVID-19

by Loud Silence Staff
May 6, 2020
US Health

Carnival to Resume Some U.S.-Based Cruises

by Loud Silence Staff
May 6, 2020
Why Clinicians’ Spiritual Health Matters in the COVID-19 Crisis
US Health

Students Upset by USMLE Response to COVID-19 Demand Changes

by Loud Silence Staff
May 5, 2020
As Society Reopens, Not Everyone is Ready
US Health

As Society Reopens, Not Everyone is Ready

by Loud Silence Staff
May 5, 2020
Why Clinicians’ Spiritual Health Matters in the COVID-19 Crisis
US Health

Why Your Kids Should Spend Time Outdoors

by Loud Silence Staff
May 5, 2020
Next Post
Ex-Apple employees start Fix The Mask to make masks with rubber bands

Ex-Apple employees start Fix The Mask to make masks with rubber bands

Recommended

Galamsey’ queen’ Aisha Huang re-arrested and remanded by Accra Court

Galamsey’ queen’ Aisha Huang re-arrested and remanded by Accra Court

September 5, 2022
Time to reflect a ‘blessing in disguise’ for Lions’ Whiteley

Time to reflect a ‘blessing in disguise’ for Lions’ Whiteley

April 20, 2020

Categories

  • African Business
  • African Education
  • African Health
  • African News
  • African Politics
  • African ShowBiz
  • Education
  • Ghana Business
  • Ghana News
  • Ghana ShowBiz
  • Ghana Sports
  • Human Interest Stories
  • News
  • Opinion
  • People
  • ShowBiz
  • Social Trends
  • US Business
  • US Education
  • US Health
  • US News
  • US Politics
  • US Showbiz
  • WADR
  • World Business
  • World News
  • World Politics
  • World Showbiz
  • World Sports

Don't miss it

Minority makes a strategic change of leadership in parliament with Ato Forson as Minority leader.
Ghana News

Minority makes a strategic change of leadership in parliament with Ato Forson as Minority leader.

January 24, 2023
Kusi Boateng’s JNS has never paid taxes neither have they ever filed annual tax returns – Okudzeto Ablakwa
Ghana News

Kusi Boateng’s JNS has never paid taxes neither have they ever filed annual tax returns – Okudzeto Ablakwa

January 23, 2023
Akufo Addo Spent ¢10bn of Covid-19 funds on ‘budget support’ – Auditor-General’s report
Ghana News

Akufo Addo Spent ¢10bn of Covid-19 funds on ‘budget support’ – Auditor-General’s report

January 23, 2023
OSP Kissi Agyebeng Protects NPA Boss Mustapha Hamid Over Illegal Contract
Ghana News

OSP Kissi Agyebeng Protects NPA Boss Mustapha Hamid Over Illegal Contract

January 22, 2023
Hon. Okudzeto Ablakwa Exposes Serious Criminal conduct Of Kusi Boateng Who is the Secretary of the Board of Trustees of Akufo Addo’s Cathedral
Ghana News

Hon. Okudzeto Ablakwa Exposes Serious Criminal conduct Of Kusi Boateng Who is the Secretary of the Board of Trustees of Akufo Addo’s Cathedral

January 16, 2023
It’s so late deserting the already Sunk ship – Mahama jabs Alan, Afriyie Akoto
Ghana News

It’s so late deserting the already Sunk ship – Mahama jabs Alan, Afriyie Akoto

January 13, 2023

About Us

LOGO

Loud Silence Radio & TV Network and is a multi media production company focusing on Ghanaian and African news.

Contact

  • Alexandria, Virginia, USA
  • +1 212-602-9641
  • loudsilenceradio@gmail.com
Facebook Twitter Youtube Linkedin

Download App

google play store

© 2021 Loud Silence Media. All rights reserved.

  • About us
  • Contact us
  • Donate
  • Live Stream
  • Privacy Policy
  • Terms of Use
Menu
  • About us
  • Contact us
  • Donate
  • Live Stream
  • Privacy Policy
  • Terms of Use
No Result
View All Result
  • Ghana News
    • General News
    • Business
    • Education
    • Opinion
  • US News
    • Business
    • Health
    • Human Interest Stories
    • Politics
    • Education
  • Africa News
    • Business
    • Education
    • Health
    • Politics
  • ShowBiz
    • Ghana ShowBiz
    • US Showbiz
    • African ShowBiz
    • World Showbiz
  • Editorials
    • People
  • World News
    • Politics
    • Business
    • Education
    • Health
  • Sports
    • Ghana Sports
    • World Sports
  • WADR
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.